Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021

SELL
$262.71 - $351.17 $281,887 - $376,805
-1,073 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$285.92 - $355.13 $379,415 - $471,257
-1,327 Reduced 55.29%
1,073 $342,000
Q2 2020

Aug 18, 2020

SELL
$141.4 - $257.09 $172,649 - $313,906
-1,221 Reduced 33.72%
2,400 $580,000
Q1 2020

May 21, 2020

BUY
$130.51 - $196.01 $143,561 - $215,611
1,100 Added 43.63%
3,621 $526,000
Q4 2019

Feb 18, 2020

BUY
$159.31 - $223.54 $5,575 - $7,823
35 Added 1.41%
2,521 $430,000
Q3 2019

Nov 19, 2019

BUY
$175.89 - $279.23 $6,332 - $10,052
36 Added 1.47%
2,486 $442,000
Q4 2018

Feb 22, 2019

BUY
$281.08 - $444.25 $14,054 - $22,212
50 Added 2.08%
2,450 $796,000
Q3 2018

Nov 15, 2018

BUY
$354.53 - $449.75 $850,871 - $1.08 Million
2,400 New
2,400 $1.08 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.